Kanda Tatsuo, Sasaki Reina, Masuzaki Ryota, Takahashi Hiroshi, Mizutani Taku, Matsumoto Naoki, Nirei Kazushige, Moriyama Mitsuhiko
Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.
Int J Mol Sci. 2020 Sep 2;21(17):6384. doi: 10.3390/ijms21176384.
Hepatitis A virus (HAV) infection occasionally leads to a critical condition in patients with or without chronic liver diseases. Acute-on-chronic liver disease includes acute-on-chronic liver failure (ACLF) and non-ACLF. In this review, we searched the literature concerning the association between HAV infection and chronic liver diseases in PubMed. Chronic liver diseases, such as metabolic associated fatty liver disease and alcoholic liver disease, coinfection with other viruses, and host genetic factors may be associated with severe hepatitis A. It is important to understand these conditions and mechanisms. There may be no etiological correlation between liver failure and HAV infection, but there is an association between the level of chronic liver damage and the severity of acute-on-chronic liver disease. While the application of an HAV vaccination is important for preventing HAV infection, the development of antivirals against HAV may be important for preventing the development of ACLF with HAV infection as an acute insult. The latter is all the more urgent given that the lives of patients with HAV infection and a chronic liver disease of another etiology may be at immediate risk.
甲型肝炎病毒(HAV)感染偶尔会导致患有或未患有慢性肝病的患者出现危急情况。慢加急性肝病包括慢加急性肝衰竭(ACLF)和非ACLF。在本综述中,我们在PubMed上检索了有关HAV感染与慢性肝病之间关联的文献。慢性肝病,如代谢相关脂肪性肝病和酒精性肝病、与其他病毒的合并感染以及宿主遗传因素,可能与严重甲型肝炎有关。了解这些情况和机制很重要。肝衰竭与HAV感染之间可能没有病因学关联,但慢性肝损伤程度与慢加急性肝病的严重程度之间存在关联。虽然接种HAV疫苗对于预防HAV感染很重要,但开发抗HAV病毒药物对于预防以HAV感染作为急性损伤的ACLF的发生可能很重要。鉴于感染HAV且患有另一种病因的慢性肝病的患者生命可能面临直接风险,后者更为紧迫。